Literature DB >> 21680513

Hepatitis C virus infection causes cell cycle arrest at the level of initiation of mitosis.

Rathi P Kannan1, Lucinda L Hensley, Lauren E Evers, Stanley M Lemon, David R McGivern.   

Abstract

Chronic infection with the hepatitis C virus (HCV) is associated with increased risk for hepatocellular carcinoma (HCC). Chronic immune-mediated inflammation is likely to be an important factor in the development of HCV-associated HCC, but direct effects of HCV infection on the host cell cycle may also play a role. Although overexpression studies have revealed multiple interactions between HCV-encoded proteins and host cell cycle regulators and tumor suppressor proteins, the relevance of these observations to HCV-associated liver disease is not clear. We determined the net effect of these interactions on regulation of the cell cycle in the context of virus infection. Flow cytometry of HCV-infected carboxyfluorescein succinimidyl ester-labeled hepatoma cells indicated a slowdown in proliferation that correlated with abundance of viral antigen. A decrease in the proportions of infected cells in G(1) and S phases with an accumulation of cells in G(2)/M phase was observed, compared to mock-infected controls. Dramatic decreases in markers of mitosis, such as phospho-histone H3, in infected cells suggested a block to mitotic entry. In common with findings described in the published literature, we observed caspase 3 activation, suggesting that cell cycle arrest is associated with apoptosis. Differences were observed in patterns of cell cycle disturbance and levels of apoptosis with different strains of HCV. However, the data suggest that cell cycle arrest at the interface of G(2) and mitosis is a common feature of HCV infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21680513      PMCID: PMC3147967          DOI: 10.1128/JVI.00280-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

Review 1.  Hepatocellular carcinoma and hepatitis C in the United States.

Authors:  Hashem B El-Serag
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

2.  MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells.

Authors:  L S Michel; V Liberal; A Chatterjee; R Kirchwegger; B Pasche; W Gerald; M Dobles; P K Sorger; V V Murty; R Benezra
Journal:  Nature       Date:  2001-01-18       Impact factor: 49.962

3.  Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C.

Authors:  Anna S Lok; James E Everhart; Elizabeth C Wright; Adrian M Di Bisceglie; Hae-Young Kim; Richard K Sterling; Gregory T Everson; Karen L Lindsay; William M Lee; Herbert L Bonkovsky; Jules L Dienstag; Marc G Ghany; Chihiro Morishima; Timothy R Morgan
Journal:  Gastroenterology       Date:  2010-12-01       Impact factor: 22.682

Review 4.  Histone H3 phosphorylation and cell division.

Authors:  F Hans; S Dimitrov
Journal:  Oncogene       Date:  2001-05-28       Impact factor: 9.867

5.  Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability.

Authors:  M Otsuka; N Kato; K Lan; H Yoshida; J Kato; T Goto; Y Shiratori; M Omata
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

6.  Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells.

Authors:  Masanori Ikeda; MinKyung Yi; Kui Li; Stanley M Lemon
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

7.  Virus-host cell interactions during hepatitis C virus RNA replication: impact of polyprotein expression on the cellular transcriptome and cell cycle association with viral RNA synthesis.

Authors:  Frank Scholle; Kui Li; Francis Bodola; Masanori Ikeda; Bruce A Luxon; Stanley M Lemon
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

8.  Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner.

Authors:  M Majumder; A K Ghosh; R Steele; R Ray; R B Ray
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

9.  Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication.

Authors:  Keril J Blight; Jane A McKeating; Charles M Rice
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

10.  HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis.

Authors:  Keng-Hsin Lan; Meei-Ling Sheu; Shinn-Jang Hwang; Sang-Hue Yen; Shiow-Yi Chen; Jaw-Ching Wu; Yuan-Jan Wang; Naoya Kato; Masao Omata; Full-Young Chang; Shou-Dong Lee
Journal:  Oncogene       Date:  2002-07-18       Impact factor: 9.867

View more
  55 in total

Review 1.  How do persistent infections with hepatitis C virus cause liver cancer?

Authors:  Jonathan K Mitchell; Stanley M Lemon; David R McGivern
Journal:  Curr Opin Virol       Date:  2015-09-29       Impact factor: 7.090

Review 2.  Single-cell mass cytometry for analysis of immune system functional states.

Authors:  Zach B Bjornson; Garry P Nolan; Wendy J Fantl
Journal:  Curr Opin Immunol       Date:  2013-08-31       Impact factor: 7.486

3.  Early transcriptional programming links progression to hepatitis C virus-induced severe liver disease in transplant patients.

Authors:  Angela L Rasmussen; Nicolas Tchitchek; Nathan J Susnow; Alexei L Krasnoselsky; Deborah L Diamond; Matthew M Yeh; Sean C Proll; Marcus J Korth; Kathie-Anne Walters; Sharon Lederer; Anne M Larson; Robert L Carithers; Arndt Benecke; Michael G Katze
Journal:  Hepatology       Date:  2012-06-05       Impact factor: 17.425

4.  Is hepatitis C virus carcinogenic?

Authors:  Stanley M Lemon; David R McGivern
Journal:  Gastroenterology       Date:  2012-05       Impact factor: 22.682

5.  Quantitative Proteomics Reveals the Roles of Peroxisome-associated Proteins in Antiviral Innate Immune Responses.

Authors:  Mao-Tian Zhou; Yue Qin; Mi Li; Chen Chen; Xi Chen; Hong-Bing Shu; Lin Guo
Journal:  Mol Cell Proteomics       Date:  2015-06-29       Impact factor: 5.911

6.  Homogeneity tests of covariance matrices with high-dimensional longitudinal data.

Authors:  Ping-Shou Zhong; Runze Li; Shawn Santo
Journal:  Biometrika       Date:  2019-05-24       Impact factor: 2.445

7.  Near-Neighbor Interactions in the NS3-4A Protease of HCV Impact Replicative Fitness of Drug-Resistant Viral Variants.

Authors:  Nadezhda T Doncheva; Francisco S Domingues; David R McGivern; Tetsuro Shimakami; Stefan Zeuzem; Thomas Lengauer; Christian M Lange; Mario Albrecht; Christoph Welsch
Journal:  J Mol Biol       Date:  2019-04-30       Impact factor: 5.469

8.  Rapid intracellular competition between hepatitis C viral genomes as a result of mitosis.

Authors:  Brian Webster; Silke Wissing; Eva Herker; Melanie Ott; Warner C Greene
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

Review 9.  Hepatitis D and hepatocellular carcinoma.

Authors:  Zaigham Abbas; Minaam Abbas; Sarim Abbas; Lubna Shazi
Journal:  World J Hepatol       Date:  2015-04-18

Review 10.  The yin and yang of hepatitis C: synthesis and decay of hepatitis C virus RNA.

Authors:  You Li; Daisuke Yamane; Takahiro Masaki; Stanley M Lemon
Journal:  Nat Rev Microbiol       Date:  2015-08-10       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.